![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Kite Doses First Patient in the Phase 2 Trial of Axicabtagene Ciloleucel in Indolent B-Cell Non-Hodgkin LymphomaÂ
Kite Pharma, Inc , a leading cell therapy company announced that patients with relapsed/refractory indolent B-cell non-Hodgkin lymphoma (iNHL) are now being treated in...
Clinical Trials
Phase III Study Of Viaskin Peanut – Allergic Of Patients One To Three Years Of Age Initiated By DBV Technologies
 DBV Technologies announced that the first patient has been enrolled in EPITOPE ( EPIT in TO ddlers with PE anut Allergy), a global,...
Clinical Trials
Positive Results From The Phase 2 AESOP Trial Evaluating OCA For The Treatment Of Patients With Primary Sclerosing Cholangitis Announced By Intercept
 Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, ...
Clinical Trials
Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017
Clinical and laboratory personnel with the need to store vaccines, pharmaceuticals and other molecular or biological samples safely can benefit from a new series...
Clinical Trials
Spheryx Awarded Phase II NIH SBIR Grant to Support Extension of Total Holographic Characterization
Spheryx, Inc. announced that the National Center for Advancing Translational Science (NCATS) of the NIH has awarded the company a Phase II SBIR grant...
Clinical Trials
Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
Viking Therapeutics, Inc , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that enrollment has...
Clinical Trials
Cannabics Pharmaceuticals Receives Positive Results In Drug Sensitivity Tests On CTCs
Cannabics Pharmaceuticals Inc announced it received positive results from screening necrosis (cell death) of circulating tumor cells, from cancer patients, treated with the cannabinoids...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read